Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-07 | New | $324,997,989 | $324,997,989 | Equity Only | 06b | SEC link |
| 2020-05-07 | Amended | $388,407,514 | $263,407,514 | Equity Only | 06b | SEC link |
| 2019-12-12 | New | $125,000,000 | $125,000,000 | Equity Only | 06b | SEC link |
| 2018-05-25 | New | $300,000,000 | $300,000,000 | Equity Only | 06b | SEC link |
| 2018-01-11 | Amended | $1,214,655,040 | $3,000,001 | Equity Only | 06c | SEC link |
| 2017-11-22 | Amended | $1,211,655,039 | $238,406,074 | Equity Only | 06c | SEC link |
| 2017-04-26 | Amended | $973,248,965 | $59,224,025 | Equity Only | 06c | SEC link |
| 2017-03-14 | New | $914,024,940 | $914,024,940 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Hal Barron | Director |
| Jose Baselga | Director |
| Hans Bishop | Director, Executive |
| Brook Byers | Director |
| William Chase | Director |
| Jennifer Cook | Director, Executive |
| Min Cui | Director |
| Kaye Foster | Director |
| Kaye Foster Cheek | Director |
| Aaron Freidin | Executive |
| Catherine Friedman | Director |
| Maykin Ho | Director |
| Jeffrey Huber | Director |
| Richard Klausner | Director |
| Sarah Krevans | Director |
| Steve Mizell | Director |
| Robert Nelsen | Director |
| Josh Ofman | Executive |
| Robert Ragusa | Director, Executive |
| William Rastetter | Director |
| Gregory Summe | Director |